Zydus Lifesciences has received the final approval from the US Food and Drug Administration (FDA) for Minocycline Hydrochloride Extended-Release Tablets in 55 mg, 65 mg, and 115 mg strengths. The tablets, which are the generic version of Solodyn Tablets, are used to treat moderate to severe acne in individuals aged 12 years and above. The […]
Glenmark Pharmaceuticals has launched a topical Minocycline 4% Gel under the brand name MINYM in India for the treatment of moderate to severe acne. According to the Indian pharma company, MINYM is a potent antibacterial gel which provides a strong anti-inflammatory action. Compared to the available topical antibacterial formulations, its topical Minocycline 4% Gel offers […]
AMZEEQ FDA approval : Israeli specialty pharma company Foamix Pharmaceuticals has bagged approval from the US Food and Drug Administration (FDA) for AMZEEQ (minocycline) topical foam, 4% for the treatment of moderate to severe acne. Previously known as FMX101, AMZEEQ has been indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne […]